| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Ceftriaxon (PIJ - EU) | — | — | — |
| 2 | Ceftriaxon (PIJ - global) | — | — | — |
| 3 | Dexamethason + Gentamicin (AUS, ATR - EU) | — | — | — |
| 4 | Dexamethason + Gentamicin (AUS, ATR - global) | — | — | — |
| 5 | Gentamicin (ATR, AUS - EU) | — | — | — |
| 6 | Gentamicin (ATR, AUS - global) | — | — | — |
| 7 | Gentamicin (ILO - EU) | — | — | — |
| 8 | Gentamicin (ILO - global) | — | — | — |
| 9 | Posaconazol (TMR, SUE - EU) | — | — | — |
| 10 | Posaconazol (TMR, SUE - global) | — | — | — |
| 11 | Trimethoprim + Sulfamethoxazol (TAB - EU) | — | — | — |
| 12 | Trimethoprim + Sulfamethoxazol (TAB - global) | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acetylcystein (OTC) | — | — | — |
| 2 | Acetylcystein (LSE) | — | — | — |
| 3 | Amantadin | — | — | — |
| 4 | Atenolol + Chlortalidon | — | — | — |
| 5 | Baclofen (INF) | — | — | — |
| 6 | Beclometason (DOS) | — | — | — |
| 7 | Beclometason (NAS, NDS, SUV) | — | — | — |
| 8 | Betamethason (CRE) | — | — | — |
| 9 | Betamethason (EMU) | — | — | — |
| 10 | Betamethason (LOE) | — | — | — |
| 11 | Betamethason (SAL) | — | — | — |
| 12 | Bezafibrat (FTA, RET) | — | — | — |
| 13 | Budesonid (DOS) | — | — | — |
| 14 | Budesonid (IHP) | — | — | — |
| 15 | Buprenorphin (PFT; 3 Tage) | — | — | — |
| 16 | Buprenorphin (0,2 mg, 0,4 mg; SUT) | — | — | — |
| 17 | Cabergolin | — | — | — |
| 18 | Calcipotriol + Betamethason (SAL) | — | — | — |
| 19 | Calcipotriol + Betamethason (GEL) | — | — | — |
| 20 | Captopril + Hydrochlorothiazid | — | — | — |
| 21 | Chinin | — | — | — |
| 22 | Ciclopirox (VCR, VSU) | — | — | — |
| 23 | Clobazam (SUE) | — | — | — |
| 24 | Clobazam (TAB) | — | — | — |
| 25 | Clotrimazol Kombipackung | — | — | — |
| 26 | Codein (TAB) | — | — | — |
| 27 | Dexamethason (ATR) | — | — | — |
| 28 | Entacapon | — | — | — |
| 29 | Epinephrin (PEN) | — | — | — |
| 30 | Fentanyl (LUT) | — | — | — |
| 31 | Fesoterodin | — | — | — |
| 32 | Formoterol (6 µg; IHP) | — | — | — |
| 33 | Granisetron (FTA) | — | — | — |
| 34 | Granisetron (IFK) | — | — | — |
| 35 | Ketorolac | — | — | — |
| 36 | Maraviroc (FTA, LSE) | — | — | — |
| 37 | Metamizol (ILO) | — | — | — |
| 38 | Methocarbamol (FTA, IIL) | — | — | — |
| 39 | Moclobemid | — | — | — |
| 40 | Mometason furoat (CRE) | — | — | — |
| 41 | Mometason furoat (LOE) | — | — | — |
| 42 | Mometason furoat (SAL) | — | — | — |
| 43 | Naltrexon | — | — | — |
| 44 | Nifedipin (RET) | — | — | — |
| 45 | Sulpirid (HKP, TAB) | — | — | — |
| 46 | Tacrolimus (Prograf, Advagraf) | — | — | — |
| 47 | Terazosin | — | — | — |
| 48 | Testosteron (180 mg; ILO) | — | — | — |
| 49 | Tiaprid | — | — | — |
| 50 | Tizanidin | — | — | — |
| 51 | Tolperison | — | — | — |
| 52 | Triacylglycerollipase (40.000 PhEur.-E.) | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acarbose | — | — | — |
| 2 | Atenolol | — | — | — |
| 3 | Baclofen (TAB) | — | — | — |
| 4 | Bimatoprost (0,1 mg; 0,12 mg) | — | — | — |
| 5 | Bosutinib | — | — | — |
| 6 | Brinzolamid + Brimonidin | — | — | — |
| 7 | Budesonid (SUV) | — | — | — |
| 8 | Buprenorphin (PFT; 7 Tage) | — | — | — |
| 9 | Cetirizin (LSE, SAF, LOE, TRO) | — | — | — |
| 10 | Ciclopirox (CRE, LOE) | — | — | — |
| 11 | Cyproteron + Ethinylestradiol | — | — | — |
| 12 | Ebastin (FTA) | — | — | — |
| 13 | Eisencarboxymaltose (IID) | — | — | — |
| 14 | Fluoxetin (20 mg) | — | — | — |
| 15 | Formoterol (12 µg; HPI) | — | — | — |
| 16 | Formoterol (12 µg; IHP) | — | — | — |
| 17 | Formoterol (12,5 µg: HPI) | — | — | — |
| 18 | Ginkgoblätter Trockenextrakt (FTA) | — | — | — |
| 19 | Hydromorphon (AMP, IIL, ILO) | — | — | — |
| 20 | Isotretinoin | — | — | — |
| 21 | Lactulose (SIR) | — | — | — |
| 22 | Lansoprazol | — | — | — |
| 23 | Loperamid (RX) | — | — | — |
| 24 | Loperamid (OTC) | — | — | — |
| 25 | Loratadin | — | — | — |
| 26 | Memantin (LSE) | — | — | — |
| 27 | Methocarbamol (750 mg) | — | — | — |
| 28 | Methocarbamol (1500 mg) | — | — | — |
| 29 | Methylphenidat (RET; 30 St) | — | — | — |
| 30 | Nilotinib | — | — | — |
| 31 | Propranolol (10 mg) | — | — | — |
| 32 | Ramipril + Amlodipin | — | — | — |
| 33 | Risedronsäure | — | — | — |
| 34 | Sulfasalazin | — | — | — |
| 35 | Tacrolimus (SAL) | — | — | — |
| 36 | Triacylglycerollipase (20.000 PhEur.-E.) | — | — | — |
| 37 | Triacylglycerollipase (25.000 PhEur.-E.) | — | — | — |
| 38 | Triamcinolon acetonid (CRE) | — | — | — |
| 39 | Acetylsalicylsäure (100 mg; OTC) | — | — | — |
| 40 | Aprepitant (HKP) | — | — | — |
| 41 | Atomoxetin (HKP) | — | — | — |
| 42 | Bimatoprost (0,3 mg) | — | — | — |
| 43 | Bosentan | — | — | — |
| 44 | Brimonidin (ATR, EDP) | — | — | — |
| 45 | Buprenorphin (PFT; 4 Tage) | — | — | — |
| 46 | Buprenorphin (0,4 mg, 2 mg, 8 mg; SUT) | — | — | — |
| 47 | Cetirizin (FTA) | — | — | — |
| 48 | Dasatinib | — | — | — |
| 49 | Dimethylfumarat | — | — | — |
| 50 | Emtricitabin + Tenofovir disoproxil | — | — | — |
| 51 | Enalapril + Lercanidipin | — | — | — |
| 52 | Entecavir | — | — | — |
| 53 | Etoricoxib | — | — | — |
| 54 | Exemestan | — | — | — |
| 55 | Febuxostat | — | — | — |
| 56 | Flecainid | — | — | — |
| 57 | Hydromorphon (REK, RET) | — | — | — |
| 58 | Hydromorphon (HKP) | — | — | — |
| 59 | Irbesartan + Hydrochlorothiazid | — | — | — |
| 60 | Letrozol | — | — | — |
| 61 | Levetiracetam (FTA) | — | — | — |
| 62 | Levetiracetam (IFK) | — | — | — |
| 63 | Levocetirizin (OTC) | — | — | — |
| 64 | Mometason furoat (NAS, NDS) | — | — | — |
| 65 | Olanzapin (FTA, SMT, TAB, UTA) | — | — | — |
| 66 | Pirfenidon (FTA) | — | — | — |
| 67 | Pomalidomid | — | — | — |
| 68 | Rasagilin | — | — | — |
| 69 | Rivaroxaban | — | — | — |
| 70 | Solifenacin | — | — | — |
| 71 | Tenofovir disoproxil | — | — | — |
| 72 | Testosteron (1000 mg; ILO) | — | — | — |
| 73 | Travoprost | — | — | — |
| 74 | Valsartan | — | — | — |
| 75 | Valsartan + Hydrochlorothiazid | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acetylcystein (RX) | — | — | — |
| 2 | Budesonid (NAS,NDS) | — | — | — |
| 3 | Diclofenac (SUP) | — | — | — |
| 4 | Domperidon (FTA, TAB) | — | — | — |
| 5 | Norethisteron + Estradiol (FTA, TAB) | — | — | — |
| 6 | Famotidin | — | — | — |
| 7 | Propranolol (40 mg, 80 mg) | — | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Etoposid 1.000 mg in 50 ml Konzentrat Infusionslösungskonzentrat St a 50 ml | — | — | |
| 2 | Etoposid 100 mg, Infusionslösungskonzentrat, 5 ml Konzentrat St a 5 ml | — | — | |
| 3 | Etoposid 400 mg, Infusionslösungskonzentrat, 20 ml Konzentrat St a 20 ml | — | — | |
| 4 | Ranibizumab 1,65 mg Injektionslösung Fertigspritze St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Azithromycin 200 mg Pulver zur Herstellung einer Suspension zum Einnehmen 5 ml Fertiglsg. St a 15-20 ml | — | — | |
| 2 | Azithromycin 200 mg Pulver zur Herstellung einer Suspension zum Einnehmen 5 ml Fertiglsg. St a 30 ml | — | — | |
| 3 | Azithromycin 250 mg Filmtabletten St | — | — | |
| 4 | Azithromycin 500 mg Filmtabletten St | — | — | |
| 5 | Doxycyclin 100 mg Hartkapseln o. Tabletten St | — | — | |
| 6 | Ibandronsäure 2 mg in 2 ml Konzentrat Infusionslösungskonzentrat St | — | — | |
| 7 | Omeprazol 10 mg Magensaftresistente Hartkapseln St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Acetylcystein 200 mg Brausetabletten o. Pulver zur Herstellung einer Lösung zum Einnehmen St | — | — | |
| 2 | Acetylcystein 300 mg in 3 ml Lsg. Injektionslösung St a 3 ml | — | — | |
| 3 | Acetylcystein 600 mg Brausetabletten o. Pulver zur Herstellung einer Lösung zum Einnehmen St | — | — | |
| 4 | Acetylcystein 600 mg Tabletten St | — | — | |
| 5 | Benzylpenicillin 1 Mega I.E. Pulver zur Herstellung einer Injektions- oder Infusionslsg. St | — | — | |
| 6 | Benzylpenicillin 10 Mega I.E. Pulver zur Herstellung einer Injektions- oder Infusionslsg. St | — | — | |
| 7 | Benzylpenicillin 5 Mega I.E. Pulver zur Herstellung einer Injektions- oder Infusionslsg. St | — | — | |
| 8 | Carbidopa 25 mg, Levodopa 100 mg Retard-Tabletten St | — | — | |
| 9 | Carbidopa 50 mg, Levodopa 200 mg Retard-Tabletten St | — | — | |
| 10 | Citalopram 10 mg Filmtabletten St | — | — | |
| 11 | Citalopram 20 mg Filmtabletten St | — | — | |
| 12 | Clozapin 100 mg Tabletten St | — | — | |
| 13 | Clozapin 25 mg Tabletten St | — | — | |
| 14 | Ipratropium bromid 0,020 mg Dosieraerosol St a 10 ml | — | — | |
| 15 | Lactulose 3,3 g / 5 ml Lösung zum Einnehmen St a 500 ml | — | — | |
| 16 | Paricalcitol 0,005 mg in 1 ml Lsg. Injektionslösung St a 1 ml | — | — | |
| 17 | Pemetrexed 1.000 mg in 40 ml Konzentrat Infusionslösungskonzentrat St a 40 ml | — | — | |
| 18 | Pemetrexed 500 mg in 20 ml Konzentrat Infusionslösungskonzentrat St a 20 ml | — | — | |
| 19 | Piperacillin 4 g, Tazobactam 0,5 g Pulver zur Herstellung einer Infusionslösung St | — | — | |
| 20 | Sevelamer carbonat 2,4 g Pulver zur Herstellung einer Suspension zum Einnehmen St | — | — | |
| 21 | Spironolacton 50 mg Tabletten St | — | — | |
| 22 | Topotecan 4 mg Infusionslösungskonzentrat o. Pulver zur Herstellung eines Infusionslösungskonzentrates St | — | — | |
| 23 | Vinorelbin 10 mg in 1 ml Konzentrat Infusionslösungskonzentrat St | — | — | |
| 24 | Vinorelbin 50 mg in 5 ml Konzentrat Infusionslösungskonzentrat St | — | — |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026 |
|
— | 1 |
| Los | Titel | Auftragnehmer | Schaetzwert | Vergabewert |
|---|---|---|---|---|
| 1 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Meropenem, ATC J01DH02 für die Zeit 01.03.2024 - 28.02.2026 | — | 1 |